NASDAQ:PRVA - Nasdaq - US74276R1023 - Common Stock - Currency: USD
22.71
-0.97 (-4.1%)
The current stock price of PRVA is 22.71 USD. In the past month the price decreased by -2.7%. In the past year, price increased by 24.37%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 11.88 | 88.05B | ||
CVS | CVS HEALTH CORP | 12.02 | 82.27B | ||
DGX | QUEST DIAGNOSTICS INC | 17.94 | 18.07B | ||
LH | LABCORP HOLDINGS INC | 14.57 | 17.76B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 12.71 | 13.80B | ||
DVA | DAVITA INC | 14.05 | 10.68B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 103.22 | 9.93B | ||
CHE | CHEMED CORP | 24.36 | 8.23B | ||
HIMS | HIMS & HERS HEALTH INC | 47.85 | 5.74B | ||
CRVL | CORVEL CORP | 26.36 | 5.66B | ||
GH | GUARDANT HEALTH INC | N/A | 5.26B | ||
OPCH | OPTION CARE HEALTH INC | 25.61 | 5.13B |
Privia Health Group, Inc. engages in the provision of healthcare services. The company is headquartered in Arlington, Virginia and currently employs 1,140 full-time employees. The company went IPO on 2021-04-29. The firm collaborates with medical groups, health plans and health systems. The company enhances physician practices, improve patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The platform supports multiple provider types, enables scalable operations, and delivers patient centric in-person and virtual access to care, quality metrics, and lower cost of care. The company provides management services to each Medical Group though a local management services organization.
PRIVIA HEALTH GROUP INC
950 N. Glebe Rd., Suite 700
Arlington VIRGINIA US
CEO: Shawn Morris
Employees: 1140
Company Website: https://www.priviahealth.com/
Investor Relations: http://ir.priviahealth.com/
Phone: 15713668850
The current stock price of PRVA is 22.71 USD. The price decreased by -4.1% in the last trading session.
The exchange symbol of PRIVIA HEALTH GROUP INC is PRVA and it is listed on the Nasdaq exchange.
PRVA stock is listed on the Nasdaq exchange.
29 analysts have analysed PRVA and the average price target is 30.6 USD. This implies a price increase of 34.74% is expected in the next year compared to the current price of 22.71. Check the PRIVIA HEALTH GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
PRIVIA HEALTH GROUP INC (PRVA) has a market capitalization of 2.75B USD. This makes PRVA a Mid Cap stock.
PRIVIA HEALTH GROUP INC (PRVA) currently has 1140 employees.
PRIVIA HEALTH GROUP INC (PRVA) has a support level at 22.5 and a resistance level at 22.97. Check the full technical report for a detailed analysis of PRVA support and resistance levels.
The Revenue of PRIVIA HEALTH GROUP INC (PRVA) is expected to grow by 10.88% in the next year. Check the estimates tab for more information on the PRVA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PRVA does not pay a dividend.
PRIVIA HEALTH GROUP INC (PRVA) will report earnings on 2025-05-08, before the market open.
The PE ratio for PRIVIA HEALTH GROUP INC (PRVA) is 206.45. This is based on the reported non-GAAP earnings per share of 0.11 and the current share price of 22.71 USD. Check the full fundamental report for a full analysis of the valuation metrics for PRVA.
The outstanding short interest for PRIVIA HEALTH GROUP INC (PRVA) is 3.84% of its float. Check the ownership tab for more information on the PRVA short interest.
ChartMill assigns a technical rating of 6 / 10 to PRVA. When comparing the yearly performance of all stocks, PRVA is one of the better performing stocks in the market, outperforming 90.03% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to PRVA. No worries on liquidiy or solvency for PRVA as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months PRVA reported a non-GAAP Earnings per Share(EPS) of 0.11. The EPS decreased by -42.11% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.83% | ||
ROA | 1.27% | ||
ROE | 2.26% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 85% to PRVA. The Buy consensus is the average rating of analysts ratings from 29 analysts.
For the next year, analysts expect an EPS growth of 129.34% and a revenue growth 10.88% for PRVA